Despite technological progress, the pharmaceutical industry continues to rely on PCs running old operating systems for various critical operations.
These legacy systems often serve as the backbone for industrial equipment, production lines, and specialized software designed for and only compatible with older platforms. While such systems provide stability and ensure continuity in processes that have been refined over decades, they also present significant challenges.
With Microsoft’s planned end-of-support for Windows 10 in October 2025, the urgency to migrate to Windows 11 or alternative platforms has become a pressing concern.